Our Offerings
We specialize in cutting-edge biologics development to help our partners bring life-saving therapies to patients faster and more efficiently. Our expertise spans antibody drug conjugates (ADCs) and bioconjugate development, bioprocess development, analytical and formulation development services.
Rapidly identify optimal ADC / bioconjugate candidates using our modular toolbox. We streamline payload, linker, and conjugation strategy evaluation to accelerate early-stage decision-making.
Comprehensive biologics development support. We integrate protein engineering, process development and optimization for efficient scale-up and technology transfer.
We provide advanced analytical, formulation services and stability testing to support the comprehensive evaluation of biologics and bioconjugates.
Coming Soon.
End-to-end GMP manufacturing capabilities to be available by 2026.
Partner
With Us
Partner With Us
Xcellon Biologics is backed by successful biotech entrepreneurs and professionals from top pharmaceutical and CDMO companies including Lonza, Abzena, Amgen, MedImmune, AstraZeneca, BioNTech, Seattle Genetics, and Immunomedics.
